title: Efficacy and side effects of sevelamer hydrochloride as sole phosphate binder in peritoneal dialysis patients with severe hyperphosphatemia.
authors.affiliation: Department of Medicine, Tung Wah Hospital, Hong Kong. wkloc@hkucc.hku.hk
authors.forename: Wai Kei
authors.initials: WK
authors.lastname: Lo
authors.forename: Suk Wai
authors.initials: SW
authors.lastname: Cheng
authors.forename: Suk Yi
authors.initials: SY
authors.lastname: Ng
authors.forename: Terence Pok-Siu
authors.initials: TP
authors.lastname: Yip
authors.forename: Man Fai
authors.initials: MF
authors.lastname: Lam
authors.forename: Kai Chung
authors.initials: KC
authors.lastname: Tse
authors.forename: Sing Leung
authors.initials: SL
authors.lastname: Lui
mesh_terms: D000328:Adult; D000368:Aged; D002614:Chelating Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D054559:Hyperphosphatemia / Q000209:etiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects / Q000379:methods*; D010710:Phosphates / Q000378:metabolism*; D011073:Polyamines / Q000627:therapeutic use*; D011446:Prospective Studies; D000069603:Sevelamer; D016896:Treatment Outcome
chemical_list: D002614:Chelating Agents; D010710:Phosphates; D011073:Polyamines; D000069603:Sevelamer